BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors
Hidesuke Fukazawa(Laboratoire de Chémo-biologie synthétique et thérapeutique), Yoshimasa Uehara(Iwate Medical University)
Cited by 46
Related Papers
Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ Inactivation
|Anticancer Research|2018|11